全文获取类型
收费全文 | 58622篇 |
免费 | 4378篇 |
国内免费 | 2980篇 |
学科分类
医药卫生 | 65980篇 |
出版年
2024年 | 43篇 |
2023年 | 618篇 |
2022年 | 1034篇 |
2021年 | 2423篇 |
2020年 | 1912篇 |
2019年 | 1732篇 |
2018年 | 1729篇 |
2017年 | 1712篇 |
2016年 | 2037篇 |
2015年 | 2462篇 |
2014年 | 3588篇 |
2013年 | 3777篇 |
2012年 | 3574篇 |
2011年 | 4138篇 |
2010年 | 3455篇 |
2009年 | 3178篇 |
2008年 | 2987篇 |
2007年 | 3252篇 |
2006年 | 2828篇 |
2005年 | 2568篇 |
2004年 | 2136篇 |
2003年 | 1880篇 |
2002年 | 1515篇 |
2001年 | 1455篇 |
2000年 | 1211篇 |
1999年 | 1094篇 |
1998年 | 927篇 |
1997年 | 918篇 |
1996年 | 720篇 |
1995年 | 738篇 |
1994年 | 686篇 |
1993年 | 516篇 |
1992年 | 405篇 |
1991年 | 337篇 |
1990年 | 304篇 |
1989年 | 275篇 |
1988年 | 267篇 |
1987年 | 194篇 |
1986年 | 167篇 |
1985年 | 310篇 |
1984年 | 192篇 |
1983年 | 142篇 |
1982年 | 126篇 |
1981年 | 105篇 |
1980年 | 71篇 |
1979年 | 66篇 |
1978年 | 58篇 |
1977年 | 37篇 |
1976年 | 36篇 |
1974年 | 10篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
101.
目的 观察免费板式组合药在DOTS中对合并乙肝的涂阳肺结核病人肝损害情况。方法 比较HBsAg、HBeAg、HBcAb阳性的涂阳肺结核病人与无乙肝的涂阳肺结核病人DOTS前后肝功能损害情况。结果 合并乙肝病人肝损害发生率66.3%,无乙肝者肝损害发生率8.6%,两者相比差异有显著性(P〈0.01)。22.5%病人因肝损害需更改治疗方案。结论 DOTS中合并乙肝的病人采用板式组合药用2H3R3Z3E3/4H3R3方案易发生肝损害,对这类病人应慎用常规方案,并要密切全程观察肝功能,尽可能应用肝损害较小的抗结核药。 相似文献
102.
Tak Mao Chan Kai Chung Tse Colin S. O. Tang Kar Neng Lai Stephen K. N. Ho 《American journal of transplantation》2004,4(7):1103-1109
The natural history of lamivudine-resistant hepatitis B virus (HBV) infection in renal transplant recipients (RTx) is unclear, despite its increasing incidence. Twenty-nine HBsAg-positive RTx with rising HBV DNA received lamivudine therapy. The course of lamivudine-resistant HBV infection was studied prospectively. During 68.7 +/- 12.5 months of follow-up, 14 (48.3%) patients developed lamivudine resistance, at 10-35 months (mean 16.9 +/- 7.0). All showed mutant sequences at codons 552 and 528 of the YMDD motif, while 13 patients demonstrated wild-type sequence at codon 555. Lamivudine resistance was unrelated to patient demographics, HBeAg status/sero-conversion, or genotype. Following resistance, HBV DNA and alanine aminotransferase showed an initial increase followed by spontaneous gradual reduction. The subsequent peak HBV DNA was lower (1.26 +/- 1.09 x 10(9) vs. 6.26 +/- 12.23 x 10(9) copies/mL, p = 0.011), while that of alanine aminotransferase was higher (196 +/- 117 vs. 77 +/- 47 imicro/l, p = 0.005), compared with pretreatment levels. Post-resistance hepatitic flare occurred in 11 (78.6%) patients. This was transient in four (36.4%), but became chronic in six (54.5%) patients. Decompensation was noted in one patient during this flare, but all survived. We conclude that drug resistance is prevalent in lamivudine-treated RTx. Despite a lower ensuing peak viremia compared with baseline, hepatitic flare is common. While most patients have spontaneous resolution, a minority may develop potentially fatal decompensation during the preceding exacerbation. 相似文献
103.
金桂红 《安徽卫生职业技术学院学报》2005,4(6):35-36
目的:探讨小儿腮腺炎并发中枢神经系统感染的临床特点.方法:对52例小儿腮腺炎并发中枢神经系统感染的临床资料进行回顾性总结分析.结果:3~7月份为小儿腮腺炎并发中枢神经系统感染的发病高峰季节(92.31%).发病年龄以6~12岁为主(82.69%),多发生于腮腺肿痛3天以上伴有持续发热者(78.85%),少数患者同时有其它脏器的损害,一般治疗疗效较好.结论:腮腺炎极易并发中枢神经系统感染,年长儿发生率高,应推广接种流腮活疫苗降低发病率. 相似文献
104.
Sundaram Hariharan Eric P. Cohen Brahm Vasudev Rimas Orentas Raphael P. Viscidi Justin Kakela Brian DuChateau 《American journal of transplantation》2005,5(11):2719-2724
We evaluated twenty renal transplant subjects at various stages of BKV nephritis (BKVN) for BKV-specific IgG and IgM antibodies using ELISA technique and BKV-DNA using PCR. They were divided as early onset (n = 7), stabilizing (n = 3), resolved (n = 8) and late onset (n = 2) BKVN. BKV-specific antibodies and BKV-DNA were simultaneously determined. The mean BKV-specific IgG level in early onset and stabilizing BKVN were 64 and 39 EIA units, and were significantly lower than 138 EIA units seen in resolved BKVN, P = 0.007, P = 0.008. The mean BKV-specific IgM levels in stabilizing BKVN was higher than resolved BKVN (130 vs 51 EIA units), P = 0.006. Mean plasma BKV loads for each group were 955,925, 5642 and 42 copies/mL of plasma, respectively. Prospective study in six BKVN cases revealed mean IgG, IgM levels and BKV-DNA at the time of diagnosis of BKVN as 39, 110 EIA units and 586,758 copies/mL of plasma, respectively. After a mean period of 5.2 months, IgG level increased to 120 EIA units (p = 0.0058) and had no detectable viral copies in circulation. Recovery from BKVN and elimination of BKV is associated with the development of BKV-specific IgG antibodies and this provides insight into the role of humoral immunity to BKV in the pathogenesis of BKVN. 相似文献
105.
Tae-Jin Song M.D. Ph.D. David P. Eisenberg M.D. Prasad S. Adusumilli M.D. Michael Hezel B.S. Yuman Fong M.D. 《Journal of gastrointestinal surgery》2006,10(4):532-542
The rising incidence of hepatocellular carcinoma (HCC) in western countries, along with the poor prognosis offered by present-day
treatment modalities, makes novel therapies for this disease necessary. Oncolytic herpes simplex viruses (HSV) are replication-competent
viruses that are highly effective in the treatment of a wide variety of experimental models of human malignancies. This study
seeks to investigate the effectiveness of oncolytic herpes viruses in the treatment of primary HCC cell lines. Sixteen commercially
available human HCC cell lines were studied. G207 is an attenuated, replication-competent, oncolytic HSV engineered to selectively
replicate within cancer cells. Cell lines were tested for viral sensitivity to G207 and their ability to support viral replication
using standard cytotoxicity and viral replication assays. Eleven of 16 cell lines were moderately to highly sensitive to G207
viral oncolysis. HCC cell lines additionally demonstrated the ability to support viral replication in vitro with as high as
800-fold amplification of the administered viral dose observed. G207 is cytotoxic to, and efficiently replicates within, HCC
cell lines in vitro. From these data, we suggest that oncolytic HSV therapy may have a role in the treatment of HCC, and in
vivo studies are warranted.
Presented in part at the 2005 American Hepato-Pancreato-Biliary Association Congress, Hollywood, Florida, April 14–17, 2005.
Supported by grants R01CA75461 and R01CA72632 from the National Institutes of Health, and by grant MBC-99366 from the American
Cancer Society (Yuman Fong). 相似文献
106.
107.
I. Tsunoda Yuzo Iwasaki Hiroshi Terunuma Kazuya Sako Yoshiro Ohara 《Acta neuropathologica》1996,91(6):595-602
Theiler’s murine encephalomyelitis viruses (TMEV) are divided into two subgroups on the basis of their different biological
activities. The GDVII strain produces acute polioencephalomyelitis in mice, whereas the DA strain produces demyelination with
virus persistence in the spinal cord. A comparative study of GDVII and DA strains suggested that low host immune responses
are responsible for the development of acute GDVII infection and that the persistence of infected macrophages plays a crucial
role in the development of chronic white matter lesions in DA infection. All 78 mice infected with GDVII died or became moribund
by day 13, while none of 54 mice infected with DA died. In the acute stage, the distribution of viral antigens in the central
nervous system (CNS) tissue was similar in both GDVII and DA infections, although the virus titer was higher in GDVII infection.
In DA infection, a substantial number of T cells were recruited to the CNS on day 6 when they were virtually absent in GDVII
infection. The titer of neutralizing antibody was already high on day 6 in DA infection but was negligible in GDVII infection.
Development of chronic paralytic disease from day 35 of the DA infection was accompanied by focal accumulation of viral antigen-positive
macrophages in the spinal white matter. In addition, white matter lesions comparable to those in chronic DA infection were
induced in the spinal cord within 7 days after intracerebral injection of DA-infected murine macrophages.
Received: 26 June 1995 / Revised, accepted: 27 December 1995 相似文献
108.
对我科1989-1990年中收治的婴儿肝炎综合征63例的临床表现、合并症、治疗等方面进行了分析。笔者认为婴儿肝炎综合征为一组临床症候群。病因诊断有其重要性。腹部B超检查有助于肝炎和胆道闭锁的鉴别,可作为常规检查方法。并认为用肾上腺皮质激素治疗有效。 相似文献
109.
对29例慢性乙型肝炎伴肝胆结石患者.采用Elisa和斑点杂交技术检测外周静脉血、胆管胆汁和门静脉血中乙型肝炎两对半及HBV-DNA.并比较HkAg含量.结果,外周静脉血、胆汁和门静脉血中HBsAg浓度分别为;2244.73±59722ng/ml、1181.65±370.91ng/ml、2013.62±483.47ng/ml;HBV-DNA阳性检出率分别为62.07%(18例),72.41%(21例)及68.97%(20例).提示肝细胞内复制的HHV在进入血循环的同时,部分随胆汁的分泌排入肠道,并可能通过受损肠粘膜进入门静脉再回到肝脏,造成HBV对肝脏的重复感染。 相似文献
110.